Literature DB >> 10222421

Paraneoplastic opsoclonus-myoclonus secondary to malignant melanoma.

J R Berger1, E Mehari.   

Abstract

Opsoclonus-myoclonus is a well-described paraneoplastic syndrome that most often occurs in association with small cell carcinoma of the lung and breast carcinoma. To the best of our knowledge, we describe the first reported case of paraneoplastic opsoclonus-myoclonus occurring is association with malignant melanoma. Antineuronal antibodies were not identified despite repeated testing. No therapeutic benefit was observed following corticosteroid administration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10222421     DOI: 10.1023/a:1006189210197

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  10 in total

1.  Opsoclonus and occult neuroblastoma.

Authors:  G E Solomon; A M Chutorian
Journal:  N Engl J Med       Date:  1968-08-29       Impact factor: 91.245

Review 2.  Autoimmune central nervous system paraneoplastic disorders: mechanisms, diagnosis, and therapeutic options.

Authors:  E J Dropcho
Journal:  Ann Neurol       Date:  1995-05       Impact factor: 10.422

3.  Dermatomyositis and metastatic malignant melanoma, with complete regression of the primary lesion.

Authors:  G Sais; J Marcoval; A Juggla; N Curco; O Servitje
Journal:  Br J Dermatol       Date:  1994-06       Impact factor: 9.302

4.  Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: a distinct paraneoplastic syndrome.

Authors:  N E Anderson; C Budde-Steffen; M K Rosenblum; F Graus; D Ford; B J Synek; J B Posner
Journal:  Medicine (Baltimore)       Date:  1988-03       Impact factor: 1.889

5.  Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.

Authors:  F A Luque; H M Furneaux; R Ferziger; M K Rosenblum; S H Wray; S C Schold; M J Glantz; K A Jaeckle; H Biran; M Lesser
Journal:  Ann Neurol       Date:  1991-03       Impact factor: 10.422

Review 6.  Paraneoplastic syndromes, tumor markers, and other unusual features of malignant melanoma.

Authors:  R F Wagner; L Nathanson
Journal:  J Am Acad Dermatol       Date:  1986-02       Impact factor: 11.527

7.  Paraneoplastic retinopathy associated with antiretinal bipolar cell antibodies in cutaneous malignant melanoma.

Authors:  J M Weinstein; S E Kelman; G H Bresnick; S E Kornguth
Journal:  Ophthalmology       Date:  1994-07       Impact factor: 12.079

8.  Therapy for paraneoplastic neurologic syndromes in six patients with protein A column immunoadsorption.

Authors:  L M Cher; F H Hochberg; J Teruya; M Nitschke; R F Valenzuela; J D Schmahmann; M Herbert; H D Rosas; C Stowell
Journal:  Cancer       Date:  1995-04-01       Impact factor: 6.860

Review 9.  [Necrotizing myelopathy associated with neoplasia. A clinico-pathological study of 2 cases and a review of the literature].

Authors:  J C Martín Escudero; M Aparicio Blanco; H Borrego Pintado; A del Villar Negro; J L Carretero Sastre; C Velasco Fernández
Journal:  An Med Interna       Date:  1991-10

Review 10.  The neurobiology of the opsoclonus-myoclonus syndrome.

Authors:  M R Pranzatelli
Journal:  Clin Neuropharmacol       Date:  1992-06       Impact factor: 1.592

  10 in total
  6 in total

1.  Opsoclonus-myoclonus syndrome in an adult with malignant melanoma.

Authors:  K-Y Jung; J Youn; C-S Chung
Journal:  J Neurol       Date:  2006-05-24       Impact factor: 4.849

2.  Paraneoplastic Opsoclonus-Myoclonus Syndrome: initial presentation of non-Hodgkins lymphoma.

Authors:  Ashwani Kumar; Walter A Lajara-Nanson; Robert W Neilson
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

3.  Opsoclonus as a suspected paraneoplastic syndrome of endometrial cancer.

Authors:  Mark A Lewis; Lynn C Hartmann; Daniel H Lachance; Rafael E Jimenez
Journal:  Rare Tumors       Date:  2010-09-30

4.  Adult-onset opsoclonus-myoclonus-ataxia syndrome as a manifestation of brazilian lyme disease-like syndrome: a case report and review of literature.

Authors:  Angelina Maria Martins Lino; Raphael Ribeiro Spera; Fernando Peixoto Ferraz de Campos; Christian Henrique de Andrade Freitas; Márcio Ricardo Taveira Garcia; Leonardo da Costa Lopes; Aleksander Snioka Prokopowitsch
Journal:  Autops Case Rep       Date:  2014-03-31

5.  "Dancing eye syndrome" secondary to opsoclonus-myoclonus syndrome in small-cell lung cancer.

Authors:  S Laroumagne; Xavier Elharrar; B Coiffard; J Plojoux; H Dutau; D Breen; P Astoul
Journal:  Case Rep Med       Date:  2014-03-23

6.  Paraneoplastic opsoclonus-myoclonus syndrome secondary to melanoma metastasis form occult primary cancer.

Authors:  Jaime D Mondragón; Omar Jiménez-Zarazúa; Lourdes N Vélez-Ramírez; María Andrea Martínez-Rivera; Samnir Enríquez-Maciel; Jesús González-Guzmán; Martha Mercedes Alvarez-Delgado; Pedro Luis González-Carrillo
Journal:  Case Rep Neurol       Date:  2019-02-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.